RxDoctor Payments Data

Chetan Malhotra, MD

Internal Medicine · Massapequa, NYNPI 1821028184

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York

Medicare billing

Part B allowed, 2024
$454,935
Medicare patients
353
Services billed
5,044

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban153$81,926
OzempicSemaglutide40$49,572
MounjaroTirzepatide28$46,803
EntrestoSacubitril/Valsartan18$19,354
ProcritEpoetin Alfa14$17,007
XareltoRivaroxaban26$16,296
AbrysvoRsv Vacc, Pref A And Pref B/Pf47$14,713
Alosetron Hcl14$14,537
Midodrine Hcl29$6,976
Mesalamine DrMesalamine12$4,182
RhopressaNetarsudil Mesylate11$3,796
Omeprazole184$2,838
Duloxetine Hcl68$2,636
Metoprolol Succinate147$2,597
Potassium Chloride82$2,571

Paid to pharmacies, not to this prescriber.

Other internal medicine in Massapequa

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →